The use status of anticoagulation drugs for inpatients with nonvalvular atrial fibrillation in Southwest China
| Autor: | Shu Kun Ouyang, Yue Zhao, Kai Lu, Huan Jie Zheng, Su Xin Luo, Hua Xiao |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Hospitalized patients International Journal of General Medicine 030204 cardiovascular system & hematology Anticoagulation Treatment antiplatelet therapy 03 medical and health sciences 0302 clinical medicine oral anticoagulant Medicine In patient atrial fibrillation 030212 general & internal medicine Stroke Original Research anticoagulation therapy business.industry international normalized ratio Mean age Atrial fibrillation General Medicine medicine.disease Emergency medicine Oral anticoagulant Medical emergency business |
| Zdroj: | International Journal of General Medicine |
| ISSN: | 1178-7074 |
| Popis: | Huan Jie Zheng,Shu Kun Ouyang,Yue Zhao,Kai Lu,Su Xin Luo,Hua Xiao Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China Background: Oral anticoagulants (OACs) are effective for the prophylaxis of stroke in patients with atrial fibrillation (AF). This cross-sectional study aimed to investigate the status of anticoagulation treatment for hospitalized AF patients in Southwest China. Methods: A total of 4760 hospitalized patients with AF were enrolled from 21 hospitals in Chongqing city from January 1 to December 31, 2013. Results: Among the enrolled patients, 3785 were diagnosed with nonvalvular AF. These patients had a mean age of 74.4±10.1 years. The mean CHADS2 score of all subjects was 2.60±1.34, and 80.7% of the patients had CHADS2 ≥2. The use rate of OACs was only 11.5% for patients with a high risk for stroke (CHADS2 ≥2) and was much lower in patients from the second-level hospitals than in patients from the third-level hospitals (5.8% vs. 16.9%, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|